Keisuke Miyake

ミヤケケイスケ | Keisuke Miyake

Affiliation and department：
Job title： Assistant professor

Research field (1)： Cardiovascular surgery

Research keywords (7)：トランスレーショナル・リサーチ , Atherosclerosis , Cell sheet , Limb ischemia , Vascular and Endovascular Surgery , Medical device development , Regenerative therapy

Research theme for competitive and other funds (9)：

2024 - 2026 Development of medical device to treat infected foot wounds
2023 - 2026 動脈硬化進行メカニズムの解明およびバイオマーカーの確立
2023 - 2025 A study to develop novel regenerative therapy with iPS-MSC to achieve limb salvage in chronic limb-threatening ischemia
2023 - 2024 Study of developing a new treatment device for infected foot wounds
2023 - 2024 殺菌技術を用いた感染創傷治療デバイス開発

Show all

Papers (34)：

Keisuke Miyake, Nobuyoshi Azuma, Chugo Rinoie, Shusaku Maeda, Akima Harada, Liu Li, Itsunari Minami, Shigeru Miyagawa, Yoshiki Sawa. Regenerative Effect of Umbilical Cord-Derived Mesenchymal Stromal Cells in a Rat Model of Established Limb Ischemia. Circulation Journal. 2022. 87. 3. 412-420
Keisuke Miyake, Shigeru Miyagawa, Yoshiki Sawa. Method to Improve Administered Cells Via Intramuscular Route to Augment Efficacy of Regenerative Cell Therapy in The Field of Peripheral Artery Disease. Applied Cell Biology. 2022. 10. 1
Keisuke Miyake, Shigeru Miyagawa, Akima Harada, Yoshiki Sawa. Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease. Molecular therapy : the journal of the American Society of Gene Therapy. 2022. 30. 3. 1239-1251
Junki Yokota, Takuji Kawamura, Keisuke Miyake, Akima Harada, Takashi Shibuya, Shigeru Miyagawa. Therapeutic Effects of Clustered Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells for Chronic Hind Limb Ischemia. CIRCULATION. 2021. 144
Keisuke Miyake, Takashi Nakamura, Hironobu Fujimura, Takashi Shibuya, Yoshiki Sawa. Role of Bypass with Preoperatively Diagnosed Small Caliber Veins in Chronic Limb-Threatening Ischemia. Annals of vascular surgery. 2021. 74. 344-355

ｍore...

MISC (120)：

土井田務, 中村隆, 山角太良, 三宅啓介, 宮川繁. 当院における内シャント一次開存率の検討. 脈管学. 2022. 62. Suppl. S131-S131
三宅啓介, 中村隆, 藤村博信, 新谷隆, 澁谷卓, 宮川繁. 包括的高度慢性下肢虚血(CLTI)に対する治療-Global vascular guidelineを踏まえて- 透析CLTI患者に対するバイパスにおけるGlobal Limb Anatomic Staging Systemの重要性. 日本外科学会定期学術集会抄録集. 2022. 122回. PD-3
三宅啓介, 中村隆, 新谷隆, 藤村博信, 澁谷卓, 宮川繁. CLTI治療における患者の活動機能の重要性. 日本血管外科学会雑誌. 2022. 31. Suppl. O15-1
横田純己, 河村拓史, 三宅啓介, 原田明希摩, 渋谷卓, 宮川繁. 実臨床における慢性虚血環境を考慮した後肢虚血マウスモデル作成方法の検討. 日本血管外科学会雑誌. 2022. 31. Suppl. P21-5
三宅啓介, 中村隆, 藤村博信, 新谷隆, 澁谷卓, 宮川繁. 透析CLTI患者に対するバイパスにおけるGlobal Limb Anatomic Staging Systemの重要性. 日本外科学会定期学術集会(Web). 2022. 122nd

ｍore...

Patents (3)：

創傷治療装置及びこれに用いる創部被覆体
Cell culture for treating disease of lower extremity
Cell culture for treating disease of lower extremity

Education (2)：

2018 - 2022 Osaka University Graduate School of Medicine
2003 - 2009 Osaka University Faculty of Medicine Medical School

Committee career (3)：

2024/06 - 現在 Japanse Society for Vascular Surgery (JSVS) Council member of JSVS
2022/07 - 現在 Japanese Society for Vascular Surgery Database management committee
2022/10 - Japanese Society for Vascular Surgery (JSVS) Committee of JSVS Academy and Surgical Training (JAST)

Awards (13)：

2024/06 - Teladoc Health Best Doctors in Japan 2024-2025 Best Doctors in Japan 2024-2025
2024/03 - in Tokyo Biodesign Innovation day (Pitch contest, Mar 7, 2024 in Tokyo University) Fantastic Award
2024/02 - in Japan Med-tech Accelerators (Pitch contest, Feb 15th, 2024 in Japan Innvation Campus in California) Fantastic Award
2022/11 - Osaka University Osaka University prize
2022/03 - Japanese circulation society Cardiovascular Surgery Award

Show all

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page